Comparative Analysis of Drug-Coated Balloons - Endovascular Today
CRT-300.08 Single-Center Study Evaluating Long-Term Major Adverse Outcomes With the Use of the Lutonix Drug-Coated Balloon in Treating Infrainguinal Arterial Disease | JACC: Cardiovascular Interventions
Lutonix ® 035 Drug Coated Balloon PTA Cathether - Oaklawn Hospital
Case Study: Complex Long Lesion Intervention With the Lutonix® 035 Drug-Coated Balloon - Endovascular Today
Case Study: Complex Long Lesion Intervention With the Lutonix® 035 Drug-Coated Balloon - Endovascular Today
Lutonix™ 018 Drug Coated Balloon PTA Catheter
LUTONIX 035 (HAS
Safety of Drug-Coated Balloons: Insight from Preclinical Studies - Endovascular Today
The Use of the LUTONIX® 035 Drug Coated Balloon PTA Catheter for Challenging AV Access Stenosis - Endovascular Today
Ballon actif pour FAV d'hémodialyse : le nouveau Gold Standard
The Lutonix® drug-coated balloon: A novel drug delivery technology for the treatment of vascular disease - ScienceDirect
035 Drug Coated Balloon PTA Catheter INSTRUCTIONS FOR USE
Cardiologie interventionnelle | CNCH
Angioplasty for Restenosis with Paclitaxel 3D Animation - YouTube
The Lutonix® drug-coated balloon: A novel drug delivery technology for the treatment of vascular disease - ScienceDirect
Frontiers | The factors influencing the efficiency of drug-coated balloons
Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease | NEJM
Case Study: Complex Long Lesion Intervention With the Lutonix® 035 Drug-Coated Balloon - Endovascular Today
Angioplastie au ballon actif, où en est on?
CLINICAL INVESTIGATION PLAN CL0023-01 Version: 2.0 November 30, 2015
8mm x 60mm - 75 cm long Lutonix™ AV Drug Coated Balloon - LX3575860V | BD
SFA ISR
Long-Term Clinical Effectiveness of a Drug-Coated Balloon for the Treatment of Femoropopliteal Lesions | Circulation: Cardiovascular Interventions
